Xenon Pharmaceuticals Inc.
XENE
Revenue
16.00k
▼-248.00k▼-93.94%
3 Months ChangeAssets
798.14M
▼-37.76M▼-4.52%
3 Months ChangeLiabilities
43.24M
▲5.14M▲13.50%
3 Months ChangeFree Cash Flow
-43.37M
▼-6.75M▼-18.43%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-094109
2024-08-08
Form 8-K
ID: 0000950170-24-093933
2024-06-05
Form 8-K
ID: 0000950170-24-069318
2024-05-09
Form 10-Q
ID: 0000950170-24-057139
2024-05-09
Form 8-K
ID: 0000950170-24-056940
2024-04-19
Form 8-K
ID: 0000950170-24-046023
2024-03-08
Form 8-K
ID: 0000950170-24-028784
2024-02-29
Form 8-K
ID: 0000950170-24-023080
2023-11-30
Form 8-K
ID: 0000950170-23-067040
2023-11-27
Form 8-K
ID: 0000950170-23-066032